Oral Microbiome Products Market (2026 - 2033) Size, Share & Trends Analysis Report By Formulation Type (Prebiotics, Postbiotics, Probiotics, Synbiotics, Non-Biotic Bioactives ), By Application (Caries Management, Periodontal & Gum Health, Halitosis), By End-user, By Region, And Segment Forecasts

Oral Microbiome Products Market Summary

The global oral microbiome products market size was valued at USD 1,350.0 million in 2025 and is expected to reach USD 3,611.1 million by 2033, expanding at a CAGR of 13.1% from 2026 to 2033. The market is growing steadily as awareness of the strong connection between oral health and overall systemic health increases.

Consumers and healthcare professionals are recognizing that an imbalance in oral bacteria is linked to dental issues such as cavities, gum disease, and bad breath, as well as broader health conditions, including diabetes, cardiovascular diseases, and respiratory infections. For instance, according to the International Diabetes Federation Diabetes Atlas (2025), 11.1% of adults (1 in 9) are living with diabetes, with 46% unaware of their condition. By 2050, cases are projected to reach 853 million (1 in 8 adults), marking a 46% increase and highlighting a significant global health challenge. This growing disease burden is reinforcing the importance of preventive oral care solutions, thereby accelerating demand for microbiome-based products that support both oral and overall health.

In addition, market growth is driven by the increasing global prevalence of oral diseases and the rising burden of non-communicable diseases. Oral conditions such as dental caries, gingivitis, and periodontal disease are among the most common health issues worldwide, affecting a large proportion of both adults and children. For instance, in March 2025, according to the WHO, oral diseases, although largely preventable, represent a significant global health burden affecting people across all age groups throughout their lifetime. These conditions often lead to pain, discomfort, disfigurement, and in severe cases, even death, significantly reducing quality of life. Prevention and treatment of oral health problems are often costly and are not commonly included in national universal health coverage (UHC) benefit packages, limiting access to care. As a result, most low- and middle-income countries face inadequate availability of essential preventive and treatment services. Oral diseases are strongly linked to modifiable risk factors such as high sugar intake, tobacco use, alcohol consumption, and poor oral hygiene, which are also associated with other non-communicable diseases, along with broader social and commercial determinants of health.

The development of microbiome-based products requires strong scientific expertise in microbiology, dentistry, biotechnology, and clinical research. As a result, companies are forming partnerships with academic institutions, research organizations, and biotechnology firms to better understand the complex ecosystem of the oral microbiome and identify effective probiotic strains. These collaborations are also helping in the development of clinically validated products. Since regulatory approval and dentist acceptance depend heavily on scientific evidence, joint research initiatives and clinical trials play a crucial role in building product credibility.

In April 2026, Dr. Colleen Cutcliffe, Co-founder and CEO of Pendulum Therapeutics, stated that the collaboration demonstrates a shared commitment to advancing robust microbiome research.

"Our collaboration represents an important milestone in the continued advancement of microbiome science," said Cutcliffe. "Together, we are committed to conducting rigorous clinical research that deepens our understanding of how the gut microbiome influences systemic health—from metabolic function to skin health and women's health."

Strategic collaborations between large consumer health companies and innovative startups are accelerating product innovation and market expansion. Established companies bring strong distribution networks, brand recognition, and manufacturing capabilities, while startups contribute advanced scientific research and novel microbial technologies. In April 2026, Pendulum Therapeutics expanded its clinical research collaboration with Mayo Clinic to advance microbiome-based research. The collaboration will focus on exploring new applications of microbiome interventions in women’s health and dermatology. This initiative aims to strengthen clinical understanding of microbiome science for broader therapeutic use. Such collaborations are expected to accelerate commercialization, enhance product credibility, and drive the adoption of microbiome-based solutions across new health and wellness segments.

Market Concentration & Characteristics

The oral microbiome products market demonstrates a high degree of innovation, driven by advancements in microbiome science and precision oral care. Companies are developing probiotic based oral products, microbiome friendly toothpaste, and diagnostic kits that target harmful bacteria while preserving beneficial microbes. For instance, in May 2025, Ostia Sciences Inc. and Expert’Biome CDMO by Lallemand have developed a new oral care probiotic, SALI-10, now ready for clinical trials. The probiotic strain Streptococcus salivarius produces Salivaricin 10, a novel compound aimed at supporting oral microbiome balance and enhancing immune health. Such innovations are accelerating the shift toward targeted, science-backed oral care solutions, strengthening the market’s growth potential and competitive landscape.

Mergers and acquisitions activity in the oral microbiome products market is moderate, as larger oral care and healthcare companies are gradually entering the space through strategic partnerships and acquisitions of niche biotech firms. Established players are focusing on expanding their product portfolios and gaining access to proprietary microbiome technologies. For instance, in April 2025, Center for Microbiome Innovation at University of California San Diego partnered with Haleon to advance microbiome-based health solutions. The collaboration combines research expertise and clinical capabilities to accelerate development of innovative products supporting areas such as healthy aging, cardiovascular, and overall well-being. Such strategic collaborations and selective acquisitions are expected to steadily strengthen innovation pipelines and enhance competitive positioning within the oral microbiome products market.

Regulations have a significant impact on the oral microbiome products market, particularly as products often fall under categories such as cosmetics, dietary supplements, or medical devices. Regulatory requirements related to safety, efficacy, and labeling vary across regions, creating complexity for manufacturers. Clinical validation and compliance with health authority guidelines are critical, especially for probiotic and therapeutic claims. While regulations help ensure product quality and consumer safety, they can also slow down product approvals and market entry.

The presence of product substitutes is relatively moderate to high in the oral microbiome products market, as traditional oral care products such as toothpaste, mouthwash, and dental floss continue to dominate consumer usage. Many consumers rely on these conventional solutions, which are widely available and cost-effective. Also, chemical-based antibacterial products may compete with microbiome friendly alternatives. However, growing awareness about the importance of maintaining a balanced oral microbiome is gradually differentiating these products.

End-use concentration in the oral microbiome products market is moderate to low, as products are used across a broad consumer base, including individuals, dental clinics, and healthcare settings. The primary demand comes from retail consumers seeking preventive oral care solutions, while professional adoption by dentists and clinicians is gradually increasing. The market is not heavily dependent on a single end-use segment, which supports diversified revenue streams. However, clinical adoption is still developing, and consumer awareness varies across regions, resulting in a balanced but not highly concentrated end-use landscape.

Formulation Type Insights

The probiotics segment dominated the oral microbiome products market in 2025. Probiotic-based products help balance the oral microbiota by increasing beneficial bacteria and reducing harmful pathogens responsible for dental caries, gingivitis, and bad breath. Growth is supported by product innovations such as dentist-formulated oral probiotics that target balanced microbiome restoration. For instance, in February 2024, Biocidin Botanicals launched Dentalflora, a daily oral probiotic under its SMILE product category, aimed at supporting healthy teeth, gums, and fresh breath. The dentist-formulated product contains four research-backed probiotics and is designed to promote a balanced oral microbiome. It is naturally flavored with organic spearmint and sweetened with xylitol. These factors are expected to sustain strong demand for probiotic-based oral care products and reinforce the segment’s leading position in the oral microbiome products market.

The postbiotics segment in the oral microbiome products market is expected to grow at the fastest rate during the forecast period. Postbiotics are non-living bacterial by-products that provide health benefits without requiring live microorganisms, making them more stable than probiotics and easier to formulate into dental care products. In the oral care industry, consumers and manufacturers are focused on safety, shelf stability, and ease of use. Postbiotics meet these requirements as they are less sensitive to heat, moisture, and storage conditions. They also eliminate the risk associated with introducing live bacteria into the oral cavity, which enhances their acceptance among dentists and consumers.

Application Insights

The caries management segment dominated the oral microbiome products market in 2025 due to the high global prevalence of dental caries and increasing focus on preventive oral healthcare, supported by WHO guidelines on reducing sugar consumption and promoting early intervention strategies. For instance, in August 2025, according to the WHO, Dental caries is the most common noncommunicable disease worldwide, affecting around 2.5 billion people. It is estimated that about 2 billion people suffer from caries in permanent teeth, while 510 million children are affected in primary teeth. The main risk factor is high consumption of free sugars in foods and beverages, which significantly increases the prevalence of disease. WHO recommends limiting free sugar intake to less than 10% of total energy intake, and ideally below 5%, to reduce risk. This strong global disease burden, along with increasing emphasis on preventive care and evidence-based dietary guidelines, continues to drive the dominance of the caries management segment in the oral microbiome products market.

The Xerostomia application segment in the oral microbiome products market is expected to grow at the fastest rate during the forecast period. Xerostomia significantly disrupts oral microbial balance, leading to higher risk of dental caries, infections, and bad breath, which is driving demand for targeted microbiome-based solutions. Rising awareness among patients and healthcare professionals about the importance of saliva in maintaining oral health is further supporting market growth. Furthermore, pharmaceutical and dental companies are investing in research and development for saliva-restoring and microbiome-balancing products, which is accelerating innovation in this segment. These factors are making xerostomia a high-growth application area within the oral microbiome products market.

End-user Insights

The adult segment dominates the oral microbiome products market in 2025. Adults are more exposed to dental issues such as gum disease, bad breath, tooth decay, and microbiome imbalance, which increases their demand for preventive and therapeutic oral care products. In addition, changing lifestyles, high consumption of processed foods, stress, and smoking habits contribute to oral health concerns, further driving product usage among adults. Dental professionals also primarily recommend oral microbiome products to adult patients, strengthening adoption in this segment. Moreover, adults are more likely to use premium oral care solutions, including probiotics, mouth rinses, and advanced dental hygiene products. Therefore, the combination of higher disease prevalence, lifestyle-related risks, and stronger product adoption positions the adult segment as the dominant contributor to market revenue in 2025.

The geriatric segment of the oral microbiome products market is expected to grow at the fastest rate during the forecast period. Older adults often experience a decline in oral microbiome balance, which raises the risk of infections and chronic dental conditions, thereby increasing demand for targeted microbiome-based solutions. In addition, rising awareness among healthcare providers and caregivers about preventive oral care for seniors is further supporting adoption. Improvements in healthcare access, expanding dental care services in aging populations, and the growing focus on improving quality of life in later years are also key contributing factors. As a result, geriatric consumers are becoming a major growth driver in this market.

Regional Insights

The North America oral microbiome products market held the largest share in 2025. Product uptake is significantly driven by widespread retail pharmacy distribution, growing direct-to-consumer (DTC) marketing channels, and strict compliance with substantiated probiotic and oral care claims. Consumers in the region show a strong willingness to invest in preventive oral health solutions, particularly functional products such as probiotic gums, lozenges, capsules, and oral sprays targeting breath freshness and gum health. For instance, according to the U.S. Census Bureau, retail sales at pharmacies and drug stores reached USD 38,231 Million in December 2025, up from USD 32,918 Million in December 2023. The region’s well-established retail infrastructure, regulatory clarity, and rising consumer focus on preventive care continue to reinforce North America’s leading position in the oral microbiome products market.

U.S. Oral Microbiome Products Market Trends

The U.S. oral microbiome products market is witnessing significant growth, driven by the rising consumer awareness of the connection between oral and systemic health, including links to immunity, cardiovascular conditions, and metabolic disorders. Preventive oral care is shifting toward microbiome-balancing solutions such as probiotics, prebiotics, and postbiotics, with increasing demand for natural and chemical-free products. E-commerce and direct-to-consumer channels are accelerating adoption, supported by personalized oral care and at-home microbiome testing innovations.

Europe Oral Microbiome Products Market Trends

The Europe oral microbiome products market is witnessing strong growth, supported by increasing regulatory acceptance of probiotic and live biotherapeutic oral care products. The European Medicines Agency (EMA) and national health authorities are gradually developing clearer frameworks for microbiome-based therapies, improving product approval pathways, and boosting innovation. Strict EU regulations under the Cosmetic Regulation and Medical Device Regulation (MDR) ensure high safety and efficacy standards, encouraging clinically validated oral microbiome products solutions.

The UK oral microbiome products market is advancing through collaborations between universities and consumer health companies to drive innovation in probiotic-based oral care solutions. Academic institutions are partnering with global firms to conduct clinical trials, validate beneficial microbiome strains, and develop next-generation products such as toothpaste, mouthwash, and lozenges that focus on maintaining a balanced oral bacterial ecosystem rather than eliminating bacteria. These partnerships are enhancing the scientific credibility of oral microbiome products and supporting greater regulatory acceptance in the UK market.

The France oral microbiome products market is steadily expanding, driven by a stronger emphasis on preventive dental healthcare supported by public health initiatives that promote early diagnosis and long-term oral care. For instance, the 2nd European Conference on Dentistry and Oral Health (Dentistry 2025) was successfully held on April 16, 2025, in Paris, France. Organized by Scitechseries, the event brought together global researchers, industry professionals, and students for knowledge exchange. The conference featured expert speakers and dynamic discussions, highlighting the latest advancements and innovations in dental research. Such initiatives and collaborative platforms are expected to accelerate awareness, innovation, and adoption of oral microbiome-based products across France.

Asia Pacific Oral Microbiome Products Market Trends

The Asia Pacific oral microbiome products market is gaining momentum, driven by the rising middle-class incomes, which are increasing consumer spending on premium and functional oral care products. For instance, according to People Research on India’s Consumer Economy (PRICE), India’s economy is set for significant transformation, shifting from an aspirer-led to a middle-class driven model. Total income is projected to grow from USD 2.2 trillion in 2021 to USD 7.1 trillion by 2031, while consumer spending is expected to rise from USD 1.9 trillion to nearly USD 5.2 trillion. This strong growth in income and spending is expected to accelerate demand for advanced oral microbiome products across the region, supporting sustained market expansion.

The China oral microbiome products market is growing rapidly, driven by strong support from e-commerce platforms and digital health channels that are improving access and awareness, particularly for imported and premium products. Domestic innovation is also accelerating, with local companies investing in microbiome research and forming collaborations with global players. However, the market still faces challenges, including regulatory uncertainty regarding probiotic classification and limited long-term clinical evidence supporting product efficacy.

Latin America Oral Microbiome Products Market Trends

The Latin America oral microbiome products market is growing at a moderate pace, largely driven by the expansion of retail and pharmacy distribution channels, which serve as the main access points for consumers due to the limited presence of specialized dental clinics in many areas. Pharmacies and large retail chains are offering probiotic toothpaste, mouthwashes, and oral supplements, thereby enhancing product availability, visibility, and consumer confidence.

Middle East & Africa Oral Microbiome Products Market Trends

The MEA oral microbiome products market is gradually emerging, driven by the shift from traditional antiseptic oral care toward microbiome-balancing products, including oral probiotics, functional toothpaste, and therapeutic mouth rinses. The growing prevalence of dental caries and periodontal diseases, especially in South Africa and GCC countries, is boosting demand. Increasing disposable incomes and the expansion of premium oral care products in the UAE and Saudi Arabia are supporting market growth.

Key Oral Microbiome Products Company Insights

Some of the key companies in the oral microbiome products market include Unilever, Colgate-Palmolive Company, Procter & Gamble, BLIS Technologies, BioGaia, Oragenics, Inc, ProBiora Health, and Lallemand Inc. Organizations are focusing on increasing customer base to gain a competitive edge in the industry. Therefore, key players are taking several strategic initiatives, such as product launch, and partnerships with other major companies.

Recent Developments

• In February 2026, Gutology raised £1.8 (USD 2.1) million in new funding to accelerate the development of its oral care and synbiotic product portfolio. The company’s Oral Biome+ toothpaste is among the top-selling oral care products on Amazon UK and Planet Organic.

• In January 2026, Researchers at Fraunhofer have developed a toothpaste ingredient that selectively inhibits periodontal disease-causing bacteria while preserving the healthy oral microbiome. The innovation has been commercialized by spin-off PerioTrap into a new range of oral care products.

• In September 2025, BioGaia launched Prodentis FRESH BREATH lozenges, a microbiome-friendly oral probiotic combined with zinc. The product is designed to provide long-lasting, instant fresh breath by neutralizing odor-causing compounds and supporting healthy gums and teeth with beneficial bacteria.

• In September 2025, Boka launched its new Probiotic Toothpaste in Citrus Mint and Peppermint Blossom flavors, featuring clinically studied probiotics to support the oral microbiome and overall oral health. The product reflects rising consumer demand for fluoride-free and wellness-focused oral care solutions.

Oral Microbiome Products Market Report Scope

Global Oral Microbiome Products Market Report Segmentation

This report forecasts revenue growth at global, regional & country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global oral microbiome products market report based on formulation type, application, end-user, and region:

• Formulation Type Outlook (Revenue, USD Million, 2021 - 2033)

  • Probiotics

  • Postbiotics

  • Prebiotics

  • Synbiotics

  • Non-Biotic Bioactives

• Application Outlook (Revenue, USD Million, 2021 - 2033)

  • Caries Management

  • Periodontal & Gum Health

  • Halitosis

  • Preventive/General Wellness

  • Xerostomia

• End-user Outlook (Revenue, USD Million, 2021 - 2033)

  • Adult

  • Pediatric

  • Geriatric

• Regional Outlook (Revenue, USD Million, 2021 - 2033)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • Thailand

    • Australia

    • South Korea

  • Latin America

    • Brazil

    • Argentina

    • Columbia

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait